Evidence map›Paper›PMID 29435285›Full record

ArticleMolecular and clinical oncology2018

Significance of lung biopsy for the definitive diagnosis of lung nodules in breast cancer patients.

Kazuo Matsuura, Toshiyuki Itamoto, Midori Noma, Masahiro Ohara, Etsushi Akimoto, Mihoko Doi, Takashi Nishisaka, Koji Arihiro, Takayuki Kadoya, Morihito Okada

Open access · diamondAbstract read
In one paragraph

Article in Molecular and clinical oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Kazuo MatsuuraDepartment of Breast Surgery, Hiroshima Prefectural Hospital, Hiroshima, Hiroshima 734-8530, Japan.
Toshiyuki ItamotoDepartment of Breast Surgery, Hiroshima Prefectural Hospital, Hiroshima, Hiroshima 734-8530, Japan.
Midori NomaDepartment of Breast Surgery, Hiroshima Prefectural Hospital, Hiroshima, Hiroshima 734-8530, Japan.
Masahiro OharaDepartment of Breast Surgery, Hiroshima Prefectural Hospital, Hiroshima, Hiroshima 734-8530, Japan.
Etsushi AkimotoDepartment of Breast Surgery, Hiroshima Prefectural Hospital, Hiroshima, Hiroshima 734-8530, Japan.
Mihoko DoiDepartment of Clinical Oncology, Hiroshima Prefectural Hospital, Hiroshima, Hiroshima 734-8530, Japan.
Takashi NishisakaDepartment of Clinical Laboratory, Hiroshima Prefectural Hospital, Hiroshima, Hiroshima 734-8530, Japan.
Koji ArihiroDepartment of Pathology, Hiroshima University Hospital, Hiroshima, Hiroshima 734-8551, Japan.
Takayuki KadoyaDepartment of Surgical Oncology, Hiroshima University Hospital, Hiroshima, Hiroshima 734-8551, Japan.
Morihito OkadaDepartment of Surgical Oncology, Hiroshima University Hospital, Hiroshima, Hiroshima 734-8551, Japan.
Hiroshima Prefectural Hospital · JPHiroshima University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to evaluate the significance of lung biopsy for the modification of the treatment strategy in breast cancer patients who develop lung nodules during follow-up after breast surgery. Of 53 consecutive patients who underwent lung biopsies in two institutions (Hiroshima University Hospital and Hiroshima Prefectural Hospital, Hiroshima, Japan) between 1997 and 2014, 45 underwent lung surgery and 8 underwent percutaneous or transbronchial tumor biopsy for lung nodules developing after curative surgery for breast cancer. The indications for lung biopsy included lung nodules for which a definitive diagnosis was difficult to achieve, and those for which the treatment strategy depended on the pathological diagnosis. The lung nodules were pathologically diagnosed as primary breast cancer metastases to the lungs in 25 (47%), primary malignant lung tumors in 21 (40%) and benign disease in 7 (13%) patients. Among the 25 metastatic patients confirmed by lung biopsy, phenotype discordance was observed in 6 patients (24%). A total of 3 patients with lung metastasis proven to have estrogen or progesterone receptor upregulation by lung biopsy received endocrine therapy. Univariate analysis revealed that patients with metastatic breast cancer confirmed by lung biopsy were significantly younger and had more locally advanced primary cancers diagnosed via clinical and pathological assessment compared with patients with other diseases. Therefore, mastectomy and axillary lymph node dissection were performed more frequently in the metastasis group compared with the others group. Multivariate analysis revealed that mastectomy (P<0.001) and axillary dissection (P<0.001) were independent factors predicting that the lung nodules would be metastases from breast cancer. Lung biopsy in breast cancer patients who developed lung nodules during the follow-up period after breast cancer surgery was crucial for making a definitive diagnosis and modifying the treatment strategy, which may improve the prognosis of breast cancer patients.

Indexed as

breast cancerlung metastaseslung nodule

Identifiers

PMID29435285
PMCPMC5774462
OpenAlexW2770809577

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.